MedPath

AHLGREN JAMES

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:0

Trial Phases

1 Phases

Phase 2:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Phase 2
2 (100.0%)

Monoclonal Antibody Therapy and Colony- Stimulating Factor in Treating Patients With Metastatic Colorectal Cancer

Phase 2
Withdrawn
Conditions
Colorectal Cancer
First Posted Date
2004-05-24
Last Posted Date
2017-07-13
Lead Sponsor
James Ahlgren
Registration Number
NCT00002664
Locations
🇺🇸

George Washington University Hospital, Washington, D.C., District of Columbia, United States

Vinorelbine Plus Paclitaxel in Treating Patients With Metastatic Prostate Cancer That Is Refractory to Hormone Therapy

Phase 2
Withdrawn
Conditions
Prostate Cancer
Interventions
First Posted Date
2004-05-03
Last Posted Date
2017-07-13
Lead Sponsor
James Ahlgren
Registration Number
NCT00003622
Locations
🇺🇸

George Washington University Hospital, Washington, D.C., District of Columbia, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.